Nu Skin Enterprises, Inc. (NYSE:NUS) Director Edwina D. Woodbury Sells 1,693 Shares

Nu Skin Enterprises, Inc. (NYSE:NUS) Director Edwina D. Woodbury sold 1,693 shares of the firm’s stock in a transaction that occurred on Thursday, May 2nd. The stock was sold at an average price of $12.02, for a total value of $20,349.86. Following the transaction, the director now owns 18,095 shares of the company’s stock, valued at approximately $217,501.90. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website.

Nu Skin Enterprises Price Performance

NUS traded up $0.26 during trading on Friday, hitting $12.41. The company’s stock had a trading volume of 443,833 shares, compared to its average volume of 735,596. The firm’s 50 day moving average price is $12.66 and its two-hundred day moving average price is $16.07. The company has a quick ratio of 1.28, a current ratio of 2.13 and a debt-to-equity ratio of 0.58. Nu Skin Enterprises, Inc. has a 12 month low of $11.73 and a 12 month high of $39.38. The stock has a market capitalization of $613.30 million, a price-to-earnings ratio of 68.95 and a beta of 1.13.

Nu Skin Enterprises (NYSE:NUS) last issued its quarterly earnings data on Wednesday, February 14th. The company reported $0.37 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.29 by $0.08. Nu Skin Enterprises had a return on equity of 10.73% and a net margin of 0.44%. The firm had revenue of $488.64 million during the quarter, compared to the consensus estimate of $479.35 million. Sell-side analysts forecast that Nu Skin Enterprises, Inc. will post 1.13 earnings per share for the current fiscal year.

Nu Skin Enterprises Cuts Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, March 6th. Stockholders of record on Monday, February 26th were paid a $0.06 dividend. The ex-dividend date of this dividend was Friday, February 23rd. This represents a $0.24 annualized dividend and a dividend yield of 1.93%. Nu Skin Enterprises’s dividend payout ratio (DPR) is currently 133.34%.

Institutional Investors Weigh In On Nu Skin Enterprises

Several hedge funds and other institutional investors have recently made changes to their positions in the company. GSA Capital Partners LLP acquired a new stake in shares of Nu Skin Enterprises in the 1st quarter valued at $817,000. Fidelis Capital Partners LLC acquired a new stake in shares of Nu Skin Enterprises in the 1st quarter valued at $112,000. BNP Paribas Financial Markets increased its stake in shares of Nu Skin Enterprises by 10.9% in the 1st quarter. BNP Paribas Financial Markets now owns 114,326 shares of the company’s stock valued at $1,581,000 after buying an additional 11,220 shares during the period. Mirae Asset Global Investments Co. Ltd. grew its stake in shares of Nu Skin Enterprises by 8.6% during the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 26,077 shares of the company’s stock worth $361,000 after purchasing an additional 2,057 shares during the period. Finally, New Mexico Educational Retirement Board acquired a new stake in shares of Nu Skin Enterprises during the first quarter worth $145,000. 82.84% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities analysts recently commented on the company. StockNews.com downgraded Nu Skin Enterprises from a “buy” rating to a “hold” rating in a research report on Saturday, February 24th. DA Davidson cut their price objective on Nu Skin Enterprises from $29.00 to $21.00 and set a “neutral” rating for the company in a research report on Friday, January 5th. Four research analysts have rated the stock with a hold rating, According to data from MarketBeat, Nu Skin Enterprises presently has an average rating of “Hold” and an average target price of $23.67.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.